In our present study, we initially demonstrated that miR-206 promoted lung cancer cell (A549) death, by targeting 3′-UTR of BCL2, which encoded pro-survive protein Bcl2, and increased the casepase-3 activities. The gene discussed is BCL2; the disease is lung carcinoma.